Pancreatic Cancer Market is projected to reach US$ 5.7 billion by 2030 | Major Companies - Myriad Genetics Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company.

Market Size and Growth:

The Global Pancreatic Cancer Market size reached US$ 2.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 5.7 billion by 2030. The global Pancreatic Cancer market is expected to exhibit a CAGR of 11.1% during the forecast period (2024-2031).

The Pancreatic Cancer Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/pancreatic-cancer-market?sz

The Pancreatic Cancer Market encompasses diagnostics, therapeutics, and supportive care solutions focused on preventing, detecting, and treating pancreatic malignancies. It includes chemotherapy, targeted therapy, immunotherapy, radiation therapy, surgical interventions, and emerging precision medicines, driven by rising incidence, unmet clinical needs, ongoing research, and advances in biomarker-based diagnosis and personalized treatment approaches.

Recent Key Developments of United States:

✅ In December 2025, the FDA approved cabozantinib (Cabometyx) on March 26 for previously treated, unresectable pancreatic neuroendocrine tumors in adults and pediatric patients aged 12 and older, expanding options for this subtype.

✅ In October 2025, the FDA granted orphan drug designation to daraxonrasib from Revolution Medicines for pancreatic ductal adenocarcinoma, highlighting promising phase 1/1b trial results with a median progression-free survival of 8.8 months in metastatic cases.

Recent Key Developments of Europe:

✅ In December 2025, Theriva Biologics received EMA guidance on trial design for its pancreatic cancer drug, supporting potential immunotherapy advancement in a field lacking approved options.

✅ In November 2025, Europe's pancreatic cancer precision medicine market advanced through expanding genomic programs and clinical trials, with Germany leading due to strong infrastructure and pharma collaborations.

✅ In September 2025, the EMA's CHMP extended Lutathera's indication to adolescents aged 12 and older with unresectable or metastatic somatostatin receptor-positive gastro-entero-pancreatic neuroendocrine tumors, enhancing youth treatment access.

List of the Key Players in the Pancreatic Cancer Market:

Myriad Genetics Inc.
Pfizer Inc.
Novartis AG
Bristol-Myers Squibb Company
AstraZeneca PLC
Amgen Inc.
Viatris Inc.
Boston Scientific Corporation
Clovis Oncology
GlaxoSmithKline

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pancreatic-cancer-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Pancreatic Cancer Market:

By Treatment Type: Targeted Therapies, Chemotherapy, Surgery, Other Treatments.

By End-user: Hospitals, Specialty Clinics, Home care, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=pancreatic-cancer-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Pancreatic Cancer market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Pancreatic Cancer Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Pancreatic Cancer market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Pancreatic Cancer Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Pancreatic Cancer Market in 2025?
◆ What is the projected growth rate of the Pancreatic Cancer Market through 2033?
◆ Who are the key players in the Pancreatic Cancer Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.